The Hong Kong University of Science and Technology (HKUST) and Xunlei Limited (“Xunlei” or the Company) (Nasdaq: XNET) today announced the establishment of HKUST-Xunlei Joint Laboratory on Blockchain Technology.
Prof. KWOK Hoi-Sing, Chair Professor from the Department of Electronic and Computer Engineering and Dr. William MW Mong Professor of Nanotechnology, has been awarded the prestigious 2019 Jan Rajchman Prize by the Society for Information Display (SID). The honor recognizes an outstanding scientific or technical achievement in, or contribution to, research on flat panel displays.
Shanghai Xiao-i Robot Technology Co. Ltd (“Xiao-i”), a leading developer of artificial intelligence (AI) technologies and industry application platforms, and the Hong Kong University of Science and Technology (“HKUST”) signed a framework agreement today to jointly establish the HKUST - Xiao-i Joint Laboratory on Machine Learning and Cognitive Reasoning (“Joint Lab”).
The Hong Kong University of Science and Technology (HKUST) today launched the “Sustainable Smart Campus as a Living Lab” (SSC) – an initiative that transforms the campus into a testing ground for learning, experimenting, and advancing smart and innovative ideas to address real-life challenges.
CLP Power Hong Kong Limited ("CLP Power"), the Hong Kong University of Science and Technology ("HKUST") and the University of Strathclyde today signed an agreement to launch Hong Kong’s first joint academic and industry-run dual master’s degree program in power engineering.
The School of Engineering of the Hong Kong University of Science and Technology (HKUST) today announced its plan to turn “experiential learning” courses into compulsory courses for 800 Year 1 undergraduate students in two to three years’ time. All engineering students will have to build an engineering artifact to acquire multidisciplinary knowledge that suits what society needs.
A research team consisting of scientists from the Hong Kong University of Science and Technology (HKUST) and Beijing Tiantan Hospital have uncovered the mutational mechanism of how a rare and deadly brain cancer –secondary glioblastoma (sGBM) – progresses from its less lethal type. The groundbreaking finding has provided a therapeutic lead which may develop into a new kind of treatment for chemo-resistant patients.